dc.contributor.author
Bloch, Denise
dc.contributor.author
Diel, Patrick
dc.contributor.author
Epe, Bernd
dc.contributor.author
Hellwig, Michael
dc.contributor.author
Lampen, Alfonso
dc.contributor.author
Mally, Angela
dc.contributor.author
Marko, Doris
dc.contributor.author
Villar Fernández, María A.
dc.contributor.author
Guth, Sabine
dc.contributor.author
Landsiedel, Robert
dc.date.accessioned
2023-10-19T08:14:04Z
dc.date.available
2023-10-19T08:14:04Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/41194
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-40915
dc.description.abstract
Exposure to multiple substances is a challenge for risk evaluation. Currently, there is an ongoing debate if generic “mixture assessment/allocation factors” (MAF) should be introduced to increase public health protection. Here, we explore concepts of mixture toxicity and the potential influence of mixture regulation concepts for human health protection. Based on this analysis, we provide recommendations for research and risk assessment. One of the concepts of mixture toxicity is additivity. Substances may act additively by affecting the same molecular mechanism within a common target cell, for example, dioxin-like substances. In a second concept, an “enhancer substance” may act by increasing the target site concentration and aggravating the adverse effect of a “driver substance”. For both concepts, adequate risk management of individual substances can reliably prevent adverse effects to humans. Furthermore, we discuss the hypothesis that the large number of substances to which humans are exposed at very low and individually safe doses may interact to cause adverse effects. This commentary identifies knowledge gaps, such as the lack of a comprehensive overview of substances regulated under different silos, including food, environmentally and occupationally relevant substances, the absence of reliable human exposure data and the missing accessibility of ratios of current human exposure to threshold values, which are considered safe for individual substances. Moreover, a comprehensive overview of the molecular mechanisms and most susceptible target cells is required. We conclude that, currently, there is no scientific evidence supporting the need for a generic MAF. Rather, we recommend taking more specific measures, which focus on compounds with relatively small ratios between human exposure and doses, at which adverse effects can be expected.
en
dc.format.extent
13 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
mixture toxicity
en
dc.subject
risk evaluation
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::540 Chemie und zugeordnete Wissenschaften
dc.title
Basic concepts of mixture toxicity and relevance for risk evaluation and regulation
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00204-023-03565-6
dcterms.bibliographicCitation.journaltitle
Archives of Toxicology
dcterms.bibliographicCitation.number
11
dcterms.bibliographicCitation.pagestart
3005
dcterms.bibliographicCitation.pageend
3017
dcterms.bibliographicCitation.volume
97
dcterms.bibliographicCitation.url
https://doi.org/10.1007/s00204-023-03565-6
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie

refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1432-0738
refubium.resourceType.provider
WoS-Alert